StageSeries I | Alive
Last Raised$150M | 5 yrs ago
About Mevion Medical Systems
Mevion Medical Systems, formerly Still River Systems, is a provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion's flagship product, the MEVION S250 proton therapy platform, is the only modular, single room proton therapy system currently on the market. The MEVION S250 integrates with standard radiation therapy workflow and provides a proton therapy treatment environment at a fraction of the cost, footprint and operational complexity of conventional systems.
Missing: Mevion Medical Systems's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Mevion Medical Systems's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Mevion Medical Systems
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Mevion Medical Systems is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Mevion Medical Systems Patents
Mevion Medical Systems has filed 57 patents.
The 3 most popular patent topics include:
- Accelerator physics
- Radiation therapy
- Medical physics
Accelerator physics, Radiation therapy, Particle physics facilities, Medical physics, Particle accelerators
Accelerator physics, Radiation therapy, Particle physics facilities, Medical physics, Particle accelerators
Latest Mevion Medical Systems News
Feb 9, 2023
| DelveInsight News provided by Share this article Share this article The spinal surgery devices market is expanding rapidly due to a variety of factors such as an increase in spinal disorders worldwide, an increase in road accidents, and an increase in demand for minimally invasive surgical procedures, among others. Furthermore, the growing market demand for technologically advanced spinal surgery devices will drive the spinal surgery devices market growth in the coming years. LAS VEGAS, Feb. 9, 2023 /PRNewswire/ -- DelveInsight's Spinal Surgery Devices Market Insights report provides the current and forecast market analysis, individual leading spinal surgery devices companies' market shares, challenges, spinal surgery devices market drivers, barriers, and trends, and key spinal surgery devices companies in the market. Key Takeaways from the Spinal Surgery Devices Market Report As per DelveInsight estimates, North America is anticipated to dominate the global spinal surgery devices market during the forecast period. Notable spinal surgery devices companies such as Siemens Healthineers AG, Elekta AB, Accuray Incorporated, IBA Worldwide, C. R. Bard, Inc (BD), Isoray Inc., Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG, ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., Xoft (iCAD, Inc.), IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT - S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc., Theragenics, Optivus Proton Therapy, Inc., P-cure, and several others are currently operating in the spinal surgery devices market. In December 2022, Empirical Spine, Inc., a medical device company developing a new type of spinal implant, completed the final step in the FDA submission process for the LimiFlexTM Dynamic Sagittal TetherTM (DST). In December 2022, Spineart, a leading provider of spine surgery implants, and eCential Robotics, a growing MedTech company that designs and manufactures an open system that unifies robotics, surgical navigation, and 2D/3D robotic imaging, announced that they have entered into a long-term collaboration agreement. In October 2022, Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced positive interim results from a clinical study using the ZIPTM MIS Interspinous Fusion System. In September 2022, eCential Robotics, a French MedTech company, received 510(k) clearance from the US Food and Drug Administration (FDA) for its spine surgery platform. In July 2022, Medtronic plc, a global leader in healthcare technology, announced its UNiDTM Spine Analyzer v4.0 planning platform, which includes a new Degen Algorithm for degenerative spine procedures, has received FDA 510(k) clearance. On June 22, 2022, Medtronic reinforced the spine surgery portfolio with the Food and Drug Administration nod for the ligament-augmenting implant. On June 07, 2022, the FDA granted the 510k clearance for the Aurora Spine's Interbody fusion device. The DEXA SOLO-L ALIF device allows doctors to match the implant to patients' bone density and quality. To read more about the latest highlights related to the spinal surgery devices market, get a snapshot of the key highlights entailed in the Global Spinal Surgery Devices Market Report Spinal Surgery Devices Overview Spinal Surgery Devices Market Insights North America dominated the global spinal surgery devices market in 2021 and will continue to do so during the forecast period (2022–2027). Furthermore, the United States is the largest market in the world, with a large patient pool in the region. Rising product launches and commercialization agreements among key manufacturers and other companies are expected to drive spinal surgery devices market growth further. For example, the United States Food and Drug Administration granted 510k clearance for Aurora Spine's Interbody fusion device on June 7, 2022. The DEXA SOLO-L ALIF device allows doctors to customize the implant based on the density and quality of the patient's bone. Furthermore, Europe and the Asia-Pacific region have the most potential for future growth in the global spinal surgery devices market. Some of the contributing factors include government support, such as easy approval for bringing new products to market and simple reimbursement policies in European and Asian countries. Moreover, the enormous popularity and high adoption rate due to the availability of various options in the market are some of the key factors that are likely to drive the spinal surgery devices market. To know more about why North America is leading the market growth in the spinal surgery devices market, get a snapshot of the Spinal Surgery Devices Market Outlook The rising number of permanent or temporary disabilities caused by the increasing number of road accidents resulting in spinal cord injury is one of the key factors driving the spinal surgery devices market. In addition, rising road traffic spinal injuries and degenerative disc diseases are expected to drive growth in the global spinal surgery devices market. Furthermore, the continuous new product launches by market leaders are positively impacting the growth of spinal surgery devices. However, the higher cost of spinal surgery and devices, adverse effects caused by spinal surgery devices, and other factors may prove to be challenging factors for the growth of the spinal surgery devices market. Additionally, during the COVID-19 pandemic, the spinal surgery devices market was negatively impacted. To prevent the spread of infection, governments around the world imposed strict lockdown rules, resulting in a shortage of supply chains, raw materials, and other market resources, resulting in a decrease in the manufacturing of all medical devices, including spinal surgery devices. Furthermore, to prevent the spread of the infection, patients and physicians postponed many surgeries, reducing the number of in-patient visits in hospitals and clinics. However, the development of the COVID-19 vaccine has begun the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has begun the process of resumption of regular healthcare services such as regular out-patient visits for treatments and sessions in hospitals and clinics, thereby restoring demand for spinal surgery devices. ~6% Key Spinal Surgery Devices Companies Siemens Healthineers AG, Elekta AB, Accuray Incorporated, IBA Worldwide, C. R. Bard, Inc (BD), Isoray Inc., Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG, ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., Xoft (iCAD, Inc.), IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT - S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc., Theragenics, Optivus Proton Therapy, Inc., P-cure, among others Spinal Surgery Devices Market Assessment Spinal Surgery Devices Market Segmentation Market Segmentation By Product Type: Thoracic Fusion and Lumbar Fusion Devices (Posterior and Interbody), Cervical Fusion Devices (Anterior, and Posterior), Spine Biologics, Vertebral Compression Fracture Treatment Devices, Spinal Decompression Devices, Spinal Bone Stimulators, Non-Fusion Devices (Dynamic Stabilization Devices, Artificial Discs, Annulus Repair Discs, And Nuclear Disc Prosthesis) Market Segmentation By Technology: Spinal Fusion & Fixation, Vertebral Compression Fracture Treatment, Spinal Decompression, Motion Preservation Market Segmentation By Surgery Type: Open Surgery and Minimally Invasive Surgery Market Segmentation By End User: Hospitals, Speciality Clinics, and Ambulatory Surgical Centers Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the spinal surgery devices market are set to emerge as the trendsetter explore @ Spinal Surgery Devices Companies Table of Contents About DelveInsight Interested in knowing the spinal surgery devices market by 2027? Click to get a snapshot of the Spinal Surgery Devices Market Trends Related Reports Spinal Stenosis Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal stenosis devices companies, including Spinal Simplicity LLC, Boston Scientific Corporation, Medtronic, Stryker, Surgalign, Zimmer Biomet, NuVasive Inc, among others. Spinal Cord Stimulators Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal cord stimulators companies, including Boston, Scientific and corporation, Medtronic plc, Nevro corp., St. Jude Medical, Greatbatch and Stimwave, among others. Spine Biologics Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spine biologics companies, including Medtronic, Stryker, Collagen Matrix, Inc., Arthrex, Inc., Bioventus, Sanofi, Seikagaku Corporation, among others. Spinal Osteosynthesis Units Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal osteosynthesis units companies, including Stryker, Zimmer Biomet, Integra LifeSciences, B. Braun, Johnson & Johnson, among others.
Mevion Medical Systems Frequently Asked Questions (FAQ)
When was Mevion Medical Systems founded?
Mevion Medical Systems was founded in 2004.
Where is Mevion Medical Systems's headquarters?
Mevion Medical Systems's headquarters is located at 300 Foster Sreet, Littleton.
What is Mevion Medical Systems's latest funding round?
Mevion Medical Systems's latest funding round is Series I.
How much did Mevion Medical Systems raise?
Mevion Medical Systems raised a total of $516.1M.
Who are the investors of Mevion Medical Systems?
Investors of Mevion Medical Systems include HOPU Investment Management, YuanMing Capital, Henan Maisheng Medical Technology, China Everbright International, CHL Medical Partners and 9 more.
Who are Mevion Medical Systems's competitors?
Competitors of Mevion Medical Systems include SetPoint Medical, eNeura Therapeutics, Light Sciences Oncology, Vapotherm, Cianna Medical and 11 more.
Compare Mevion Medical Systems to Competitors
NAS Medical develops, manufactures, and sells radiation therapy products for use in cancer treatment.
Novasys Medical, formerly Genesis Medical, is a medical device company that develops therapies in women's health. The company's initial focus is the development and commercialization of the Renessa System, a non-surgical approach to the treatment of female stress urinary incontinence (SUI). The company was founded in 1999 and is based in Newark, California.
Light Sciences Oncology (LSO) is developing Talaporfin Sodium for solid tumors as well as other indications such as BPH. Talaporfin Sodium is a water-soluble drug targeted by a small, single-use, disposable drug activator included with the drug. Talaporfin Sodium is designed to provide tolerable, effective, and repeatable treatments for patients. LSO has completed treatment of patients in a Phase 3 trial of Talaporfin Soduim in hepatocellular carcinoma (HCC), a Phase 3 trial for metastatic colorectal cancer (MCRC) and in Phase 1 and Phase 2 clinical trials in benign prostatic hyperplasia (BPH), or enlargement of the prostate.
CardioOptics is a developer of Trans-Blood Vision products to provide catheter-based direct visualization through blood using infrared light.
eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.
Aspire Medical is developing a new therapy for treating obstructive sleep apnea.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.